Vivos (RDGL) Return on Sales Growth (1y) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Vivos | - | - | -3,105.00 | 161.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 161.00 |
| Sep 30, 2025 | -105.00 |
| Jun 30, 2025 | -6.00 |
| Mar 31, 2025 | 93.00 |
| Dec 31, 2024 | -56.00 |
| Sep 30, 2024 | -70.00 |
| Jun 30, 2024 | 102.00 |
| Mar 31, 2024 | -83.00 |
| Dec 31, 2023 | -40.00 |
| Sep 30, 2023 | -53.00 |
| Jun 30, 2023 | -64.00 |
| Mar 31, 2023 | 12.00 |
| Dec 31, 2022 | 7.00 |
| Sep 30, 2022 | -29.00 |
| Dec 31, 2021 | -57.00 |
| Sep 30, 2021 | 6.00 |
| Dec 31, 2020 | 278.00 |
| Sep 30, 2020 | 64.00 |
| Mar 31, 2018 | 52.00 |
| Dec 31, 2017 | -773.00 |
| Sep 30, 2017 | -826.00 |
| Jun 30, 2017 | 810.00 |
| Mar 31, 2017 | 1,329.00 |
| Dec 31, 2016 | -1,069.00 |
| Sep 30, 2016 | 171.00 |
| Jun 30, 2016 | -398.00 |
| Mar 31, 2016 | -1,563.00 |
| Dec 31, 2015 | 1,010.00 |
| Sep 30, 2015 | -26.00 |
| Jun 30, 2015 | -511.00 |
| Mar 31, 2015 | 208.00 |
| Dec 31, 2014 | -726.00 |
| Sep 30, 2014 | -176.00 |
| Jun 30, 2014 | -74.00 |
| Mar 31, 2014 | -53.00 |
| Dec 31, 2013 | 35.00 |
| Sep 30, 2013 | 28.00 |
| Jun 30, 2013 | 0.00 |
| Mar 31, 2013 | -8.00 |
| Dec 31, 2012 | -43.00 |
| Sep 30, 2012 | -25.00 |
| Jun 30, 2012 | -34.00 |
| Mar 31, 2012 | -4.00 |
| Dec 31, 2011 | -13.00 |